Both academic and enterprise software solutions exist for designing CRISPR targets. They offer advantages when designing guide RNAs (gRNAs) but often focus on a select number of model organisms. Those that offer a wide variety of organisms can be limited in support of alternative endonucleases and downstream analyses such as multitargeting and population analyses to interrogate a microbiome. To accommodate broad CRISPR utilization, we developed a flexible platform software CRISPR Associated Software for Pathway Engineering and Research (CASPER) for gRNA generation and analysis in any organism and with any CRISPR-Cas system. CASPER combines traditional gRNA design tools with unique functions such as multiple Cas-type gRNA generation and evaluation of spacer redundancy in a single species or microbiome. The analyses have implications for strain-, species-, or genus-specific CRISPR diagnostic probe design and microbiome manipulation. The novel features of CASPER are packaged in a user-friendly interface to create a computational environment for researchers to streamline the utility of CRISPR-Cas systems.
Get full access to this article
View all access options for this article.
References
1.
StovicekV, BorodinaI, ForsterJ. CRISPR–Cas system enables fast and simple genome editing of industrial Saccharomyces cerevisiae strains. Metab Eng Commun. 2015; 2:13–22. DOI: http://dx.doi.org/10.1016/j.meteno.2015.03.001.
2.
JakočiūnasT, BondeI, HerrgårdM, et al.Multiplex metabolic pathway engineering using CRISPR/Cas9 in Saccharomyces cerevisiae. Metab Eng. 2015; 28:213–222. DOI: 10.1016/j.ymben.2015.01.008.
3.
JacksonSA, McKenzieRE, FagerlundRD, et al.CRISPR-Cas: Adapting to change. Science. 2017; 356:eaal5056. DOI: 10.1126/science.aal5056.
4.
ChenJS, DoudnaJA. The chemistry of Cas9 and its CRISPR colleagues. Nat Rev Chem. 2017; 1. DOI: 10.1038/s41570-017-0078.
5.
Pickar-OliverA, GersbachCA. The next generation of CRISPR–Cas technologies and applications. Nat Rev Mol Cell Biol. 2019; 20:490–507. DOI: https://doi.org/10.1038/s41580-019-0131-5.
6.
PurseyE, SünderhaufD, GazeWH, et al.CRISPR-Cas antimicrobials: Challenges and future prospects. PLoS Pathog. 2018; 14:e1006990. DOI: 10.1371/journal.ppat.1006990.
7.
ZhuH, LiC, GaoC. Applications of CRISPR–Cas in agriculture and plant biotechnology. Nat Rev Mol Cell Biol. 2020; 21:661–677. DOI: https://doi.org/10.1038/s41580-020-00288-9.
AnzaloneAV, KoblanLW, LiuDR. Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol. 2020; 38:824-844. DOI: https://doi.org/10.1038/s41587-020-0561-9.
10.
JiangF, DoudnaJA. CRISPR-Cas9 structures and mechanisms. Annu Rev Biophys. 2017; 46:505–529. DOI: 10.1146/annurev-biophys-062215-010822.
11.
AndersC, NiewoehnerO, DuerstA, et al.Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature. 2014; 513:569. DOI: 10.1038/nature13579.
12.
MakarovaKS, KooninEV. Annotation and classification of CRISPR-Cas systems. In: CRISPR: Methods and Protocols. (LundgrenM, CharpentierE, FineranPC; eds). New York, NY: Springer. 2015; pp. 47–75.
13.
KleinstiverBP, PrewMS, TsaiSQ, et al.Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature. 2015; 523:481–485. DOI: 10.1038/nature14592.
14.
ZetscheB, GootenbergJS, AbudayyehOO, et al.Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell. 2015; 163:759–771. DOI: 10.1016/j.cell.2015.09.038.
15.
HsuPD, ScottDA, WeinsteinJA, et al.DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol. 2013; 31:827–832. DOI: 10.1038/nbt.2647.
16.
AndersonEM, HauptA, SchielJa, et al.Systematic analysis of CRISPR–Cas9 mismatch tolerance reveals low levels of off-target activity. J Biotechnol. 2015; 211:56–65. DOI: 10.1016/j.jbiotec.2015.06.427.
17.
DoenchJG, HartenianE, GrahamDB, et al.Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat Biotechnol. 2014; 32:1–13. DOI: 10.1038/nbt.3026.
18.
DoenchJG, FusiN, SullenderM, et al.Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotech. 2016; 34:184–191. DOI: 10.1038/nbt.3437.
19.
KnightSC, XieL, DengW, et al.Dynamics of CRISPR-Cas9 genome interrogation in living cells. Science. 2015; 350:823–826. DOI: 10.1126/science.aac6572.
20.
MalinaA, CameronCJF, RobertF, et al.PAM multiplicity marks genomic target sites as inhibitory to CRISPR-Cas9 editing. Nat Commun. 2015; 6:10124. DOI: 10.1038/ncomms10124.
21.
SinghD, SternbergSH, FeiJ, et al.Real-time observation of DNA recognition and rejection by the RNA-guided endonuclease Cas9. Nat Commun. 2016; 7:12778. DOI: 10.1038/ncomms12778.
RaperAT, StephensonAA, SuoZ. Functional insights revealed by the kinetic mechanism of CRISPR/Cas9. J Am Chem Soc. 2018; 140:2971–2984. DOI: 10.1021/jacs.7b13047.
24.
LinJ, WongKC. Off-target predictions in CRISPR-Cas9 gene editing using deep learning. Bioinformatics. 2018; 34:i656–i663. DOI: 10.1093/bioinformatics/bty554.
25.
ConcordetJ-P, HaeusslerM. CRISPOR: Intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens. Nucleic Acids Res. 2018; 46:W242–W245. DOI: 10.1093/nar/gky354.
26.
Moreno-MateosMA, VejnarCE, BeaudoinJD, et al.CRISPRscan: Designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo. Nat Methods. 2015; 12:982–988. DOI: 10.1038/nmeth.3543.
27.
KleinstiverBP, TsaiSQ, PrewMS, et al.Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells. Nat Biotechnol. 2016; 34:869–874. DOI: 10.1038/nbt.3620.
28.
KleinstiverBP, PattanayakV, PrewMS, et al.High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects. Nature. 2016; 529:490–495. DOI: 10.1038/nature16526.
29.
TyckoJ, BarreraLA, HustonNC, et al.Pairwise library screen systematically interrogates Staphylococcus aureus Cas9 specificity in human cells. Nat Commun. 2018; 9:2962. DOI: 10.1038/s41467-018-05391-2.
30.
LarsonMH, GilbertLA, WangX, et al.CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat Protoc. 2013; 8:2180–2196. DOI: 10.1038/nprot.2013.132.
31.
ZalatanJG, LeeME, AlmeidaR, et al.Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell. 2015; 160:339–350. DOI: 10.1016/j.cell.2014.11.052.
32.
PetersJM, ColavinA, ShiH, et al.A comprehensive, CRISPR-based functional analysis of essential genes in bacteria. Cell. 2016; 165:1493–1506. DOI: https://doi.org/10.1016/j.cell.2016.05.003.
33.
QiLS, LarsonMH, GilbertLA, et al.Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell. 2013; 152:1173–1183. DOI: 10.1016/j.cell.2013.02.022.
34.
KomorAC, KimYB, PackerMS, et al.Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. 2016; 533:420–424. DOI: 10.1038/nature17946.
35.
EidA, AlshareefS, MahfouzMM. CRISPR base editors: Genome editing without double-stranded breaks. Biochem J. 2018; 475:1955–1964. DOI: 10.1042/BCJ20170793.
36.
LabunK, MontagueTG, KrauseM, et al.CHOPCHOP v3: Expanding the CRISPR web toolbox beyond genome editing. Nucleic Acids Res. 2019; 47:W171–W174. DOI: 10.1093/nar/gkz365.
37.
EsveltKM, MaliP, BraffJL, et al.Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat Methods. 2013; 10:1116–1121. DOI: 10.1038/nmeth.2681.
38.
MendozaBJ, TrinhCT. Enhanced guide-RNA design and targeting analysis for precise CRISPR genome editing of single and consortia of industrially relevant and non-model organisms. Bioinformatics. 2018; 34:16–23. DOI: 10.1093/bioinformatics/btx564.
39.
BikardD, EulerCW, JiangW, et al.Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat Biotechnol. 2014; 32:1146–1150. DOI: 10.1038/nbt.3043.
BeiselCL, GomaaAA, BarrangouR. A CRISPR design for next-generation antimicrobials. Genome Biol. 2014; 15:516. DOI: 10.1186/s13059-014-0516-x.
42.
WangT, WeiJJ, SabatiniDM, et al.Genetic screens in human cells using the CRISPR-Cas9 system. Science. 2014; 343:80–84. DOI: 10.1126/science.1246981.
43.
LinY, CradickTJ, BrownMT, et al.CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences. Nucleic Acids Res. 2014; 42:7473–7485. DOI: 10.1093/nar/gku402.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
